Search company, investor...

Founded Year

2014

Stage

Series A | Alive

Total Raised

$9.32M

Last Raised

$9.32M | 4 yrs ago

About SamanTree Medical

SamanTree Medical develops the Histolog Scanner, a digital microscopy scanner for ultra-fast confocal imaging of fresh excisions. It reveals the morphology of the tissue at the subcellular level. In the treatment of cancer, the Histolog Scanner can help surgeons to visualize the excision's margins.

Headquarters Location

Rue de Genève 88b

Lausanne, 1004,

Switzerland

+41 21 625 09 40

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Expert Collections containing SamanTree Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SamanTree Medical is included in 2 Expert Collections, including Digital Health.

D

Digital Health

10,563 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

O

Oncology Tech

457 items

This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.

SamanTree Medical Patents

SamanTree Medical has filed 16 patents.

The 3 most popular patent topics include:

  • Microscopy
  • Medical imaging
  • Spectroscopy
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/29/2020

9/5/2023

Optical devices, Optical components, Microscopy, Photography equipment, Spectroscopy

Grant

Application Date

4/29/2020

Grant Date

9/5/2023

Title

Related Topics

Optical devices, Optical components, Microscopy, Photography equipment, Spectroscopy

Status

Grant

Latest SamanTree Medical News

Appointments and promotions in diverse startups

Aug 7, 2023

Background 07.08.2023 SamanTree Medical, Salutacoach, and Betterview have appointed new leaders to occupy the role of Chief Executive Officer. The newly Deputy CEO at Klarpay wears different hats in the company. There have been changes at Bloom Biorenewables: the two co-founders will become CO-CEOs while two team leads have been promoted to CTO and CIO. SamanTree Medical , a medical technology company specializing in innovative solutions to improve cancer treatment, has appointed Olivier Delporte to the position of Chief Executive Officer (CEO). Olivier Delporte joins SamanTree Medical with a proven track record of leadership in the medical technology industry. Olibier brings over 22 years of experience driving growth and innovation of fast-growing companies across various therapeutic areas. He joins the company at animportant phase in SamanTree’s growth. The company is currently focusing on scaling commercial placements of the Histolog® Scanner in Europe and planning the US market expansion for 2024. The Histolog®Scanner has already been used in more than 2000 surgical procedures and the adoption is accelerating. As the new CEO, Olivier Delporte will be responsible for overseeing the company’s strategic vision and driving global expansion. Salutacoach Salutacoach , provider of personal online health coaching programs to optimise metabolic health has bid farewell to Lukas Zahner as CEO who will take on the role of Chairman of the Board of Directors, to accompany the start-up on a strategic level. His successor Angela Metzger has played a major role in shaping and advancing the company since her first day. She has grown incredibly quickly in her tasks, learned a lot and successfully mastered countless challenges in the process. Additionally, the startup from the University of Basel welcomed new members including Anja Amann who will lead the Operations and Corporate Health department. Betterview Michael Wendt is the new CEO at Betterview , the startup offers laser eye treatments at a fixed price. endt most recently served as CEO of bestsmile, but has accompanied betterview since its founding as an investor and advisor. In his new role, he will primarily be responsible for the areas of finance and HR, as well as the expansion of digital processes. As a new member of the management team, Michael Wendt will play a key role in the further development of betterview. The company offers laser eye treatments at a fixed price and has just opened its fifth clinic within a year. Under the leadership of Michael Wendt, David Holenstein and Rouven Mayer, betterview plans to further strengthen its market position and drive growth. Klarpay Klarpay AG has welcomed Markus Emödi to his new role as Chief Legal & Compliance Officer and Deputy CEO. With a track record of over 20 years in the financial industry, Markus brings a wealth of experience and expertise to Klarpay. Markus Emödi is a legal professional who has dedicated his career to compliance and risk management within the financial sector. His knowledge in regulatory areas such as anti-money laundering (AML), securities law, asset management, and payment transactions make him an invaluable asset to the Klarpay team. In his new role as the Chief Legal & Compliance Officer, Markus will play a key role in driving Klarpay's operations forward and facilitating its continued growth trajectory. He will be responsible for overseeing and enhancing Klarpay's legal and compliance functions. Bloom fills two executive positions To support its fast growth, Bloom Biorenewables , the startup providing a novel, cost-competitive route to source molecules from plants, has appointed Ydna Questell-Santiago and Philip Sholten as Chief Technology Officer (CTO) and Chief Innovation Officer (CIO), respectively. Both Ydna and hilip have been part of the Bllom family last year supporting the company in its mission to provide unprecedented alternatives for many petroleum-based products technology. The startup’s co-founders and Florent Héroguel will also share the co-CEO position. (RAN)

SamanTree Medical Frequently Asked Questions (FAQ)

  • When was SamanTree Medical founded?

    SamanTree Medical was founded in 2014.

  • Where is SamanTree Medical's headquarters?

    SamanTree Medical's headquarters is located at Rue de Genève 88b, Lausanne.

  • What is SamanTree Medical's latest funding round?

    SamanTree Medical's latest funding round is Series A.

  • How much did SamanTree Medical raise?

    SamanTree Medical raised a total of $9.32M.

  • Who are the investors of SamanTree Medical?

    Investors of SamanTree Medical include b2venture, Sioux, BOM Brabant Ventures, Panakes Partners, European Commission and 4 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.